株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

免疫化学分析装置:医療機器のパイプライン評価

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 351424
出版日 ページ情報 英文 396 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
免疫化学分析装置:医療機器のパイプライン評価 Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2016
出版日: 2016年12月01日 ページ情報: 英文 396 Pages
概要

当レポートでは、免疫化学分析装置のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における最近の出来事などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 免疫化学分析装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域 (国) 別
  • パイプライン製品:規制経路別
  • パイプライン製品:承認時期別 (推定)
  • 継続中の治験

第4章 免疫化学分析装置 - 開発中のパイプライン製品:企業別

  • 免疫化学分析装置 Companies - パイプライン製品:開発段階別
  • パイプライン製品:開発段階別

第5章 免疫化学分析装置の開発企業と製品の概要の概要

  • Acreo Swedish ICT AB
  • AESKU.Diagnostics GmbH & Co. KG
  • Akonni Biosystems, Inc.
  • Arcxis Biotechnologies Inc.
  • Assay Dynamics, LLC
  • Atonomics A/S
  • Beckman Coulter, Inc.
  • BioMedomics, Inc
  • BioNanovations Corporation
  • BioSIMS
  • Boston University
  • Canon U.S.A., Inc.
  • CardioGenics Inc.
  • Celsee Diagnostics, Inc.
  • Cepheid
  • China Medical Technologies, Inc.
  • ChipCare Corp
  • Clearbridge BioLoc Pte Ltd
  • Corgenix Medical Corporation
  • Courtagen Life Sciences, Inc.
  • Curetis N.V.
  • Denator AB
  • DiaSorin S.p.A
  • Dyamed Biotech Pte Ltd
  • Dynex Technologies
  • EKF Diagnostics Holdings Plc
  • Enigma Diagnostics Limited
  • F Cubed LLC
  • Firalis SAS
  • First Light Biosciences, Inc.
  • Florida State University
  • GenePOC Inc.
  • Genera Biosystems Limited
  • Genevo Biosystems Pte Ltd
  • GenMark Diagnostics, Inc.
  • Global Solutions for Infectious Diseases
  • GNA Biosolutions GmbH
  • Harvard University
  • HeatFlow Technologies, Inc.
  • Hologic, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Immunexpress Pty Ltd
  • Immunodiagnostic Systems Holdings plc
  • Intelligent Fingerprinting Ltd
  • Johnson & Johnson
  • LaserGen, Inc.
  • Lucerna, Inc.
  • Magellan Diagnostics, Inc.
  • Magnisense SAS
  • MAST GROUP Ltd.
  • Maxygen-mobile DNA tests
  • mBio Diagnostics, Inc.
  • McKesson Corporation
  • MedNostic Technologies, LLC
  • Mindray Medical International Limited
  • Mobidiag Ltd.
  • NanoLab, Inc.
  • Nanosphere, Inc.
  • Next Dimension Technologies, Inc.
  • NorthShore University Health System
  • OncoGenesis
  • Optidet Diagnostics Ltd
  • Optofluidics, Inc.
  • Ostendum R&D BV
  • Polymedco CDP, LLC
  • Protomex Life Sciences
  • Qiagen N.V.
  • Quanterix Corporation
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Radisens Diagnostics Limited
  • Raman Diagnostics Limited
  • Rapid Biosensor Systems
  • Rapid Diagnostek, Inc.
  • Siemens Healthcare Diagnostics Inc.
  • Siloam Biosciences, Inc.
  • Singulex, Inc.
  • Spire Corporation
  • Stat-Diagnostica & Innovation, S.L.
  • STRATEC Molecular GmbH
  • Sysmex Corporation
  • Tecan Group Ltd
  • Techcomp (Holdings) Limited
  • The Palo Alto Research Center
  • TrovaGene, Inc.
  • Tyncbest Biotechnology
  • University of California, Davis
  • University of California, San Diego
  • University of Michigan
  • University of Michigan Pediatric Device Consortium
  • Wellstat Diagnostics, LLC
  • Xanthostat Diagnostics, Inc.
  • ZIN Technologies, Inc.

第6章 免疫化学分析装置 - 最近の出来事

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0257EPD

GlobalData's Medical Devices sector report, "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Immunochemistry Analyzers Overview

3. Products under Development

  • 3.1. Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • 3.2. Immunochemistry Analyzers - Pipeline Products by Segment
  • 3.3. Immunochemistry Analyzers - Pipeline Products by Territory
  • 3.4. Immunochemistry Analyzers - Pipeline Products by Regulatory Path
  • 3.5. Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
  • 3.6. Immunochemistry Analyzers - Ongoing Clinical Trials

4. Immunochemistry Analyzers - Pipeline Products under Development by Companies

  • 4.1. Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
  • 4.2. Immunochemistry Analyzers - Pipeline Products by Stage of Development

5. Immunochemistry Analyzers Companies and Product Overview

  • 5.1. Acreo Swedish ICT AB Company Overview
  • 5.2. AgPlus Diagnostics LTD Company Overview
  • 5.3. Akers Biosciences, Inc. Company Overview
  • 5.4. Akonni Biosystems, Inc. Company Overview
  • 5.5. Amic AB (Inactive) Company Overview
  • 5.6. ApoCell Inc Company Overview
  • 5.7. Arcxis Biotechnologies Inc Company Overview
  • 5.8. Assay Dynamics LLC (Inactive) Company Overview
  • 5.9. Atonomics A/S Company Overview
  • 5.10. Attophotonics Biosciences GmbH Company Overview
  • 5.11. Beckman Coulter Inc Company Overview
  • 5.12. Becton Dickinson and Company Company Overview
  • 5.13. Binghamton University Company Overview
  • 5.14. Bio-Alternative Medical Devices Ltd Company Overview
  • 5.15. BioMedomics Inc Company Overview
  • 5.16. bioMerieux S.A. Company Overview
  • 5.17. BioNanovations Corporation Company Overview
  • 5.18. Biopico Systems Inc. Company Overview
  • 5.19. BioSIMS Company Overview
  • 5.20. Boditech Med Inc. Company Overview
  • 5.21. Boston University Company Overview
  • 5.22. BreviTest Technologies LLC Company Overview
  • 5.23. Canon U.S.A., Inc. Company Overview
  • 5.24. CardioGenics Inc. Company Overview
  • 5.25. Cepheid Company Overview
  • 5.26. China Medical Technologies Inc (Inactive) Company Overview
  • 5.27. ChipCare Corp Company Overview
  • 5.28. Clearbridge BioLoc Pte Ltd Company Overview
  • 5.29. Co-Diagnostics HBDC, Inc. Company Overview
  • 5.30. Corgenix Medical Corp Company Overview
  • 5.31. Courtagen Life Sciences Inc Company Overview
  • 5.32. Curetis NV Company Overview
  • 5.33. Denator AB Company Overview
  • 5.34. DiaSorin S.p.A Company Overview
  • 5.35. Dyamed Biotech Pte Ltd Company Overview
  • 5.36. Dynex Technologies Company Overview
  • 5.37. EKF Diagnostics Holdings Plc Company Overview
  • 5.38. EMD Millipore Corp Company Overview
  • 5.39. Enigma Diagnostics Limited Company Overview
  • 5.40. Firalis SAS Company Overview
  • 5.41. First Light Biosciences, Inc. Company Overview
  • 5.42. GenePOC Inc. Company Overview
  • 5.43. Genera Biosystems Ltd Company Overview
  • 5.44. Genevo Biosystems Pte Ltd Company Overview
  • 5.45. Genomas Inc Company Overview
  • 5.46. Global Solutions for Infectious Diseases Company Overview
  • 5.47. GNA Biosolutions GmbH Company Overview
  • 5.48. Great Basin Corp Company Overview
  • 5.49. Harvard University Company Overview
  • 5.50. HeatFlow Technologies, Inc. Company Overview
  • 5.51. Hologic Inc Company Overview
  • 5.52. Indian Institute of Technology, Madras Company Overview
  • 5.53. Indiana University Company Overview
  • 5.54. Jana Care Inc. Company Overview
  • 5.55. John Hopkins University Company Overview
  • 5.56. LabNow Inc (Inactive) Company Overview
  • 5.57. LaserGen, Inc. Company Overview
  • 5.58. Lucerna Inc Company Overview
  • 5.59. Magellan Diagnostics Inc Company Overview
  • 5.60. Magna Diagnostics GmbH Company Overview
  • 5.61. MAST GROUP Ltd. Company Overview
  • 5.62. Maxygen-mobile DNA tests Company Overview
  • 5.63. mBio Diagnostics, Inc. Company Overview
  • 5.64. McKesson Corporation Company Overview
  • 5.65. MedNostic Technologies, LLC Company Overview
  • 5.66. Mesa Biotech Inc Company Overview
  • 5.67. MML Ltd Company Overview
  • 5.68. Mobidiag Ltd Company Overview
  • 5.69. Molecular Warehouse Ltd Company Overview
  • 5.70. Nalia Systems Ltd Company Overview
  • 5.71. NanoLab, Inc. Company Overview
  • 5.72. Nanomix Inc Company Overview
  • 5.73. Nanosphere Inc Company Overview
  • 5.74. Newcastle University Company Overview
  • 5.75. NorthShore University Health System Company Overview
  • 5.76. Ohmx Corp Company Overview
  • 5.77. OncoGenesis Company Overview
  • 5.78. OncoTherapy Science Inc Company Overview
  • 5.79. Optofluidics, Inc. Company Overview
  • 5.80. Ortho-Clinical Diagnostics Inc Company Overview
  • 5.81. Ostendum R&D BV Company Overview
  • 5.82. Pharmahungary Group Company Overview
  • 5.83. Phoenix Biosystems Inc Company Overview
  • 5.84. POC Medical Systems Inc. Company Overview
  • 5.85. Polymedco CDP, LLC Company Overview
  • 5.86. PositiveID Corp Company Overview
  • 5.87. Protomex Life Sciences Company Overview
  • 5.88. Qiagen NV Company Overview
  • 5.89. Quanterix Corp Company Overview
  • 5.90. Radisens Diagnostics Ltd Company Overview
  • 5.91. Raman Diagnostics Limited Company Overview
  • 5.92. Rapid Diagnostek, Inc. Company Overview
  • 5.93. Roche Diagnostics International Ltd Company Overview
  • 5.94. Royal College of Surgeons in Ireland Company Overview
  • 5.95. Sebia SA Company Overview
  • 5.96. SenGenix Inc Company Overview
  • 5.97. Singulex Inc Company Overview
  • 5.98. Stat-Diagnostica & Innovation, S.L. Company Overview
  • 5.99. STRATEC Molecular GmbH Company Overview
  • 5.100. Sysmex Corporation Company Overview
  • 5.101. TearLab Corp Company Overview
  • 5.102. Tecan Group Ltd Company Overview
  • 5.103. Techcomp (Holdings) Limited Company Overview
  • 5.104. The Palo Alto Research Center Company Overview
  • 5.105. Thermal Gradient Inc Company Overview
  • 5.106. Trinity Biotech Plc Company Overview
  • 5.107. Tyncbest Biotechnology Company Overview
  • 5.108. University of Alberta Company Overview
  • 5.109. University of California Berkeley Company Overview
  • 5.110. University of California Davis Company Overview
  • 5.111. University of California San Diego Company Overview
  • 5.112. University of Michigan Company Overview
  • 5.113. University of Michigan Pediatric Device Consortium Company Overview
  • 5.114. Vircell SL Company Overview
  • 5.115. ViroCyt, Inc. Company Overview
  • 5.116. Wellstat Diagnostics LLC Company Overview
  • 5.117. Xanthostat Diagnostics Inc Company Overview
  • 5.118. ZIN Technologies, Inc. Company Overview

6. Immunochemistry Analyzers- Recent Developments

  • 6.1. Nov 17, 2016: ChipCare Raises USD2.1 Million in Series B Financing
  • 6.2. Nov 14, 2016: HTG Molecular Diagnostics Reports Third Quarter 2016 Results
  • 6.3. Nov 10, 2016: Response Biomedical Announces Third Quarter 2016 Financial Results
  • 6.4. Nov 10, 2016: Siemens intends to further strengthen its healthcare business
  • 6.5. Nov 09, 2016: John Wayne Cancer Institute Enters into Research Agreement with Clearbridge Biomedics
  • 6.6. Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments
  • 6.7. Nov 08, 2016: Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results
  • 6.8. Nov 07, 2016: Roka Bioscience Reports Third Quarter 2016 Financial Results
  • 6.9. Nov 07, 2016: Changes in the AYOXXA Management Team
  • 6.10. Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
  • 6.11. Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results
  • 6.12. Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
  • 6.13. Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
  • 6.14. Nov 02, 2016: Lak Ananth to head new next47 startup unit
  • 6.15. Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
  • 6.16. Nov 02, 2016: NanoString Technologies Releases Operating Results for Third Quarter of 2016
  • 6.17. Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
  • 6.18. Oct 31, 2016: Zenosense MIDS Cardiac Bench Reader Development
  • 6.19. Oct 27, 2016: Novacyt Half Year 2016 Results
  • 6.20. Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook
  • 6.21. Oct 27, 2016: Cempra Reports Third Quarter 2016 Financial Results and Provides Corporate Update
  • 6.22. Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results
  • 6.23. Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results
  • 6.24. Oct 26, 2016: Psychemedics Announces Record Revenues and Earnings
  • 6.25. Oct 24, 2016: LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche
  • 6.26. Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report
  • 6.27. Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update
  • 6.28. Oct 20, 2016: ViroCyt Develops Rapid Detection System For Enterovirus 71
  • 6.29. Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016
  • 6.30. Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
  • 6.31. Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution
  • 6.32. Oct 13, 2016: General Biologicals to Raise up to USD10.2 Million in Public Offering of Shares
  • 6.33. Oct 13, 2016: THERADIAG: Very strong revenue growth at end-September 2016: +31%
  • 6.34. Oct 06, 2016: Eagle Biosciences Enters into Distribution Agreement with AroCell
  • 6.35. Oct 04, 2016: Trinity Biotech Announces FDA 510(k) Submission withdrawal for Meritas Point of Care Analyzer Africa

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • Table 2: Immunochemistry Analyzers - Pipeline Products by Segment
  • Table 3: Immunochemistry Analyzers - Pipeline Products by Territory
  • Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path
  • Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
  • Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials
  • Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
  • Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • Table 9: Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Electronic Nanowire Bio - Sensor - Product Status
  • Table 11: Electronic Nanowire Bio - Sensor - Product Description
  • Table 12: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: AgPlus Diagnostic System - Product Status
  • Table 14: AgPlus Diagnostic System - Product Description
  • Table 15: Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: minDNAnalyzer - Product Status
  • Table 17: minDNAnalyzer - Product Description
  • Table 18: Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Point-Of-Care Device - Tuberculosis - Product Status
  • Table 20: Point-Of-Care Device - Tuberculosis - Product Description
  • Table 21: Amic AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Optical Fluorescence Reader - Product Status
  • Table 23: Optical Fluorescence Reader - Product Description
  • Table 24: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: ApoStream System - Product Status
  • Table 26: ApoStream System - Product Description
  • Table 27: Arcxis Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: BioPhalanx Analyzer - Product Status
  • Table 29: BioPhalanx Analyzer - Product Description
  • Table 30: Assay Dynamics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Automated Diagnostic Device - Product Status
  • Table 32: Automated Diagnostic Device - Product Description
  • Table 33: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Atolyzer Consumer Device - Product Status
  • Table 35: Atolyzer Consumer Device - Product Description
  • Table 36: Atolyzer Gene - Product Status
  • Table 37: Atolyzer Gene - Product Description
  • Table 38: Atolyzer PoC - Product Status
  • Table 39: Atolyzer PoC - Product Description
  • Table 40: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Nanoparticle Microfluidic Color Device - Product Status
  • Table 42: Nanoparticle Microfluidic Color Device - Product Description
  • Table 43: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: DxN VERIS MDx System - Product Status
  • Table 45: DxN VERIS MDx System - Product Description
  • Table 46: UniCel DxN - Product Status
  • Table 47: UniCel DxN - Product Description
  • Table 48: Becton Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: BD Viper LT System - HPV - Product Status
  • Table 50: BD Viper LT System - HPV - Product Description
  • Table 51: Becton Dickinson and Company - Ongoing Clinical Trials Overview
  • Table 52: BD Viper LT System - HPV - Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System with Cervical Specimens
  • Table 53: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Ultra-Sensitive Portable Capillary Sensor - Product Status
  • Table 55: Ultra-Sensitive Portable Capillary Sensor - Product Description
  • Table 56: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Magnetic Immunoassay Detection System - Product Status
  • Table 58: Magnetic Immunoassay Detection System - Product Description
  • Table 59: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Next Generation Ultra-sensitive Nanotube Platform - Product Status
  • Table 61: Next Generation Ultra-sensitive Nanotube Platform - Product Description
  • Table 62: TR-LFIA Diagnostic Platform - Product Status
  • Table 63: TR-LFIA Diagnostic Platform - Product Description
  • Table 64: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Magnotech System - Product Status
  • Table 66: Magnotech System - Product Description
  • Table 67: BioNanovations Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: TestQuick - Product Status
  • Table 69: TestQuick - Product Description
  • Table 70: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: MONITOR System - Product Status
  • Table 72: MONITOR System - Product Description
  • Table 73: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: DigiPLEX Analyzer - Product Status
  • Table 75: DigiPLEX Analyzer - Product Description
  • Table 76: Boditech Med Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: AFIAS6 - Product Status
  • Table 78: AFIAS6 - Product Description
  • Table 79: I-Chroma Ifob With I-Chroma Reader - Product Status
  • Table 80: I-Chroma Ifob With I-Chroma Reader - Product Description
  • Table 81: Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Lab-On-A-Chip - Thyroid Cancer - Product Status
  • Table 83: Lab-On-A-Chip - Thyroid Cancer - Product Description
  • Table 84: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status
  • Table 85: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description
  • Table 86: Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever - Product Status
  • Table 87: Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever - Product Description
  • Table 88: BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: BreviTest Portable Analyzer - Product Status
  • Table 90: BreviTest Portable Analyzer - Product Description
  • Table 91: Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Automated Diagnostic System - Infectious Disease - Product Status
  • Table 93: Automated Diagnostic System - Infectious Disease - Product Description
  • Table 94: CardioGenics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: QL Care Analyzer - Product Status
  • Table 96: QL Care Analyzer - Product Description
  • Table 97: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: GeneXpert Omni - Product Status
  • Table 99: GeneXpert Omni - Product Description
  • Table 100: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status
  • Table 101: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description
  • Table 102: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: AUTOLIA-12/48 - Product Status
  • Table 104: AUTOLIA-12/48 - Product Description
  • Table 105: SPR Analyzer - Product Status
  • Table 106: SPR Analyzer - Product Description
  • Table 107: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Portable Cell Analyzer - Food Borne Diseases - Product Status
  • Table 109: Portable Cell Analyzer - Food Borne Diseases - Product Description
  • Table 110: Portable Cell Analyzer - HIV - Product Status
  • Table 111: Portable Cell Analyzer - HIV - Product Description
  • Table 112: Portable Cell Analyzer - Malaria - Product Status
  • Table 113: Portable Cell Analyzer - Malaria - Product Description
  • Table 114: Portable Cell Analyzer - Tuberculosis - Product Status
  • Table 115: Portable Cell Analyzer - Tuberculosis - Product Description
  • Table 116: Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 117: AssayQuest - Product Status
  • Table 118: AssayQuest - Product Description
  • Table 119: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: LightPCR - Product Status
  • Table 121: LightPCR - Product Description
  • Table 122: Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 123: ELISA Microplate Reader - Product Status
  • Table 124: ELISA Microplate Reader - Product Description

List of Figures

  • Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development
  • Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment
  • Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory
  • Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path
  • Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
  • Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials
Back to Top